Baldelovar, Mei-ann B.
HRN: 22-92-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/08/2024
06/15/2024
IVT
500 MG
Q8
ACUTE APPENDICITIS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes